Ftse Mib
33.235,42
-0,24%
DAX
18.067,91
-0,31%
S&P 500
5.487,03
0,25%
NASDAQ
17.862,23
0,03%
Bitcoin
64.746,06
-0,60%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Europa EU OSE Immunotherapeutics (OSE) OSE Immunotherapeutics (OSE) Notizie

OSE Immunotherapeutics

OSE
5,85
-0,29 (-4,72%)
19 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: Euronext
Tipo: Azione Ordinaria
Valuta: EUR

Ultime notizie

Data Ora Fonte Titolo
19/6/202418:15GLOBEOSE Immunotherapeutics Reports on its 2024 General..
12/6/202418:00GLOBEWebinaire KOL Investisseurs d’OSE Immunotherapeutics : le..
05/6/202407:30GLOBEOSE Immunotherapeutics and Nantes University Hospital..
04/6/202418:00GLOBEInformations relatives au nombre total de droits de vote et..
30/5/202418:15GLOBEOSE Immunotherapeutics fait le point sur ses avancées et sur..
29/5/202418:00GLOBEMise à disposition des documents préparatoires à ..
22/5/202407:30GLOBEOSE Immunotherapeutics et Boehringer Ingelheim étendent leur..
13/5/202418:00GLOBEInformations relatives au nombre total de droits de vote et..
02/5/202418:00GLOBEMise à disposition du Document d’Enregistrement Universel ..
16/4/202418:00GLOBEOSE Immunotherapeutics’ Global License to Develop a Novel..
10/4/202418:00GLOBEOSE Immunotherapeutics reçoit un financement public de 8,4..
03/4/202418:00GLOBEInformations relatives au nombre total de droits de vote et..
02/4/202407:30GLOBEOSE Immunotherapeutics annonce une publication sur CLEC-1,..
27/3/202418:00BWOSE Immunotherapeutics Reports Full Year 2023 Financial..
18/3/202407:30BWOSE Immunotherapeutics Announces Completion of Enrollment in..
01/3/202418:00BWOSE Immunotherapeutics : Informations relatives au nombre..
28/2/202407:45BWOSE Immunotherapeutics to Host a Live Webcast to Discuss..
28/2/202407:30BWAbbVie et OSE Immunotherapeutics annoncent un partenariat..
26/2/202418:00BWOSE Immunotherapeutics présente les dernières données sur..
02/2/202418:00BWOSE Immunotherapeutics : Informations relatives au nombre..
19/1/202407:30BWOSE Immunotherapeutics fait un point d’étape sur les..
05/1/202418:00BWOSE Immunotherapeutics : Informations relatives au nombre..
11/12/202307:30BWOSE Immunotherapeutics and Nantes University Hospital..
05/12/202318:00BWOSE Immunotherapeutics : Informations relatives au nombre..
21/11/202318:00BWOSE Immunotherapeutics annonce un accord de collaboration..
06/11/202318:00BWOSE Immunotherapeutics : Informations relatives au nombre..
23/10/202318:00BWOSE Immunotherapeutics Announces First Clinical Results for..
16/10/202307:30BWOSE Immunotherapeutics présente les premiers résultats..
05/10/202318:00BWOSE Immunotherapeutics : Informations relatives au nombre..
27/9/202318:03BWOSE Immunotherapeutics Announces H1 2023 Results and..
20/9/202307:30BWOSE Immunotherapeutics présente les avancées de ses..
11/9/202318:00BWOSE Immunotherapeutics Announces: Positive Phase 3 Data from..
04/9/202318:00BWOSE Immunotherapeutics : Informations relatives au nombre..
01/8/202307:30BWOSE Immunotherapeutics Announces New Public Grant to Support..
19/7/202318:00BWOSE Immunotherapeutics Announces Publication in Frontiers in..
11/7/202318:00BWOSE Immunotherapeutics and Nantes University Hospital..
10/7/202318:00BWOSE Immunotherapeutics : Informations relatives au nombre..
06/7/202307:30BWOSE Immunotherapeutics Announces for Lusvertikimab, its..
04/7/202318:00BWOSE Immunotherapeutics Announces New US Patent Granted for..
22/6/202318:00BWOSE Immunotherapeutics : Résultats de l’Assemblée générale..
20/6/202318:00BWOSE Immunotherapeutics Receives €1.5 M in Funding from..
Apertura: 6,08 Min: 5,71 Max: 6,14
Chiusura: 6,14

La tua Cronologia

EU
OSE
OSE Immunotherapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network